Clinical experience with Optivate®, high-purity factor VIII (FVIII) product with von Willebrand factor (VWF) in young children with haemophilia A
- 作者M. MATYSIAK; H. BOBROWSKA; W. BALWIERZ; A. CHYBICKA; J. R. KOWALCZYK; R. SHAIKH-ZAIDI; K. GILLANDERS; C. H. DASH
- 卷第17卷
- 期第5期
- 印刷ISSN1351-8216
- 电子ISSN1365-2516
- 文件大小73.07KB
- 发表时间2011
- DOI10.1111/j.1365-2516.2011.02600.x
Diabetes mellitus, impaired fasting glucose, atherosclerotic risk factors, and prevalence of coronary heart diseaseCharles M Alexander; Pamela B Landsman; Steven M Teutsch · 2000
Prevalence and risk factors of extra-coronary atherosclerotic disease in patients with confirmed coronary artery disease: A Cross-Sectional Study in Abidjan Heart InstituteKouamé, M.; Niamkey, J.; Matanga, J.; Yao, H.; Ekou, A.; Kouakou, H.; Konin, C.; Anzouan-Kacou, J.; Nâguetta, R. · Archives of Cardiovascular Diseases Supplements · 2020
Coronary atherosclerosis and cardiovascular mortality in hemophiliaC. J. FOLEY; L. NICHOLS; K. JEONG; C. G. MOORE; M. V. RAGNI · 2010
Pulmonary embolism in sickle cell disease: a case–control studyE. M. NOVELLI; C. HUYNH; M. T. GLADWIN; C. G. MOORE; M. V. RAGNI · 2012
Challenges of rare disease research: limited patients and competing prioritiesM. V. RAGNI; C. G. MOORE; V. BIAS; N. S. KEY; P. A. KOUIDES; C. W. FRANCIS; for the Hemostasis Thrombosis Research Society (HTRS) · 2012
Screening for von Willebrand disease in children: a case–control studyH. C. BUJNICKI; R. F. SIDONIO; C. KEMPTON; P. A. KOUIDES; R. KULKARNI; D. J. NUGENT; D. L. YEE; C. G. MOORE; M. V. RAGNI · 2011
Impact of HIV on liver fibrosis in men with hepatitis C infection and haemophiliaM. V. RAGNI; C. G. MOORE; K. SOADWA; M. A. NALESNIK; A. B. ZAJKO; A. CORTESE-HASSETT; T. L. WHITESIDE; S. HART; A. ZEEVI; J. LI; O. S. SHAIKH; THE HHH STUDY GROUP · 2011